Skip to content
Screener

C4 Therapeutics CCCC Q3 2025 earnings

Reported November 6, 2025 · Before market open

Revenue$11.2MBeat by $6.8M
EPS-$0.44Beat by $0.03
Revenue estimate$4.5M
EPS estimate-$0.47

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$4.8M
EPS estimate-$0.21

FAQ

When did C4 Therapeutics report Q3 2025 earnings?
C4 Therapeutics (CCCC) reported Q3 2025 earnings on November 6, 2025 before market open.
What were C4 Therapeutics's Q3 2025 revenue and EPS?
C4 Therapeutics reported revenue of $11.2M and eps of $-0.44 for Q3 2025.
Did C4 Therapeutics beat estimates in Q3 2025?
Revenue beat the consensus estimate of $4.5M by $6.8M. EPS beat the consensus estimate of $-0.47 by $0.03.
How did C4 Therapeutics's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 26.9% from $15.4M a year earlier and eps declined 25.7% from $-0.35.
Where can I find C4 Therapeutics's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001628280-25-049850) and the 10-Q periodic report (0001628280-25-049854) directly on SEC EDGAR. The filing index links above go to sec.gov.